ABSTRACT Objective: Severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) is a novel coronavirus identified in December 2019 in Wuhan, China. There is limited data on coronavirus disease-2019 (COVID-19) in patients with solid and hematologic malignancies, and the incidence of SARS-COV-2 in cancer patients with respiratory symptoms is not characterized. We report on...